USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY AND PROMOTE NEUROPROTECTION

MA53437AUndetermined Publication Date: 2021-06-30MINERVA NEUROSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA53437
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-04-09
Filing Date
2019-08-21
Publication Date
2021-06-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.